Literature DB >> 8098072

Resistance modifying agents are active in some patients with hematological malignancy.

P Reizenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8098072     DOI： 10.1016/0145-2126(93)90015-d

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  1 in total

1.  Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal.

Authors:  V Nüssler; R Pelka-Fleischer; H Zwierzina; C Nerl; B Beckert; E Gullis; F Gieseler; S Bock; R Bartl; P E Petrides
Journal:  Ann Hematol       Date:  1994       Impact factor: 3.673
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.